Literature DB >> 11288973

Elevated plasma levels of interleukin-2 and soluble IL-2 receptor in ischemic heart disease.

A D Simon1, S Yazdani, W Wang, A Schwartz, L E Rabbani.   

Abstract

BACKGROUND: T-lymphocytes are present in significant numbers in the atherosclerotic plaque, but their role in the progression and pathogenesis of coronary syndromes remains poorly understood. HYPOTHESIS: We sought to determine the relationship between T-lymphocyte activation and ischemic heart disease by measuring plasma levels of cytokines related to T-lymphocyte function in patients with stable and unstable angina.
METHODS: Plasma levels of interleukin-2 (IL-2) and soluble IL-2 receptor (sIL-2R) were measured in 105 patients: 66 with stable angina, 24 with unstable angina, and 15 healthy controls. Patients who presented to the cardiac catheterization laboratory with unstable or stable anginal syndromes for coronary angiography or percutaneous coronary intervention enrolled in the study.
RESULTS: Mean levels of IL-2 were significantly higher in patients with stable angina than in those with unstable angina. The differences between stable angina and control groups, or between unstable angina and control groups, were not statistically significant. Mean levels of slL-2R were significantly higher in patients with stable angina than in either patients with unstable angina or control patients.
CONCLUSIONS: Levels of IL-2 and sIL-2 receptor are significantly elevated in patients with stable angina, but not in patients with unstable angina. The contribution of T-lymphocytes to the development of both stable and unstable angina requires further investigation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11288973      PMCID: PMC6654814          DOI: 10.1002/clc.4960240315

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  8 in total

1.  Differentiating ischemic from non-ischemic chest pain using white blood cell-surface inflammatory and coagulation markers.

Authors:  Tatyana Levinas; Elizabeth Eshel; Adi Sharabi-Nov; Alon Marmur; Najib Dally
Journal:  J Thromb Thrombolysis       Date:  2012-08       Impact factor: 2.300

2.  Inflammatory markers in a 2-year follow-up of coronary artery disease.

Authors:  Katarzyna Mizia-Stec; Zbigniew Gasior; Barbara Zahorska-Markiewicz; Michał Holecki; Paweł Kumor
Journal:  Heart Vessels       Date:  2006-09-29       Impact factor: 2.037

3.  Effect of interleukin-2 level and genetic variants on coronary artery disease.

Authors:  Ru Ding; Wenwu Gao; David H Ostrodci; Zhiqing He; Yuanlin Song; Lan Ma; Chun Liang; Zonggui Wu
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

4.  Heat-sensitive moxibustion attenuates the inflammation after focal cerebral ischemia/ reperfusion injury.

Authors:  Aijiao Xiao; Rixin Chen; Mingfei Kang; Shenghai Tan
Journal:  Neural Regen Res       Date:  2012-11-25       Impact factor: 5.135

5.  Interleukin-2 and Interferon-Gamma Single Nucleotide Polymorphisms in Iranian Patients with Chronic Heart Failure.

Authors:  Mohammad Jafar Mahmoudi; Sara Harsini; Elham Farhadi; Mona Hedayat; Mohammad Taghvaei; Maryam Mahmoudi; Maryam Sadr; Nilufar Esfahanian; Ebrahim Nematipour; Keramat Nourijelyani; Ali Akbar Amirzargar; Nima Rezaei
Journal:  Avicenna J Med Biotechnol       Date:  2018 Jul-Sep

6.  Levels of serum IL-1beta, IL-2, IL-8 and tumor necrosis factor-alpha in patients with unstable angina pectoris.

Authors:  Ali Ozeren; Mustafa Aydin; Mehmet Tokac; Nejat Demircan; Murat Unalacak; Ahmet Gurel; Mehmet Yazici
Journal:  Mediators Inflamm       Date:  2003-12       Impact factor: 4.711

7.  Cardiovascular diabetology in the core of a novel interleukins classification: the bad, the good and the aloof.

Authors:  Enrique Z Fisman; Michael Motro; Alexander Tenenbaum
Journal:  Cardiovasc Diabetol       Date:  2003-09-12       Impact factor: 9.951

8.  Cytokine Disturbances in Coronary Artery Ectasia Do Not Support Atherosclerosis Pathogenesis.

Authors:  Usama Boles; Anders Johansson; Urban Wiklund; Zain Sharif; Santhosh David; Siobhan McGrory; Michael Y Henein
Journal:  Int J Mol Sci       Date:  2018-01-16       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.